February 14, 2019
A pre-clinical study at Toronto General Hospital Research Institute has shown the effectiveness of light-based therapies in clearing donor livers of active hepatitis C. By treating the infected donor organs with UV light, they were able to inactivate the RNA in the hepatitis C virus, meaning the virus could no longer infect the cells of the recipient. If this treatment proves effective in further trials it has the potential to reduce waiting times for organ transplant, lower the risks to recipients, and reduce the cost to the healthcare system.
Source: Research 2 Reality
Read more: http://ow.ly/gZXm30nDuMC